Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: To assess decisional conflict and knowledge about prematurity among mothers facing extreme premature delivery when the counseling clinicians were randomized to counsel using a validated decision aid compared with usual counseling.

Study Design: In this randomized trial, clinicians at 5 level III neonatal intensive care units in the US were randomized to supplement counseling using the decision aid or to counsel mothers in their usual manner. We enrolled mothers with threatened premature delivery at 22 to 25 weeks of gestation within 7 days of their counseling. The primary outcome was the Decisional Conflict Scale (DCS) score. One hundred mothers per group were enrolled to detect a clinically relevant effect size of 0.4 in the Decisional Conflict Scale. Secondary outcomes included knowledge about prematurity; scores on the Preparedness for Decision Making scale; and acceptability.

Results: Ninety-two clinicians were randomized and 316 mothers were counseled. Of these, 201 (64%) mothers were enrolled. The median gestational age was 24.1 weeks (IQR 23.7-24.9). In both groups, DCS scores were low (16.3 ± 18.2 vs 16.8 ± 17, P = .97) and Preparedness for Decision Making scores were high (73.4 ± 28.3 vs 70.5 ± 31.1, P = .33). There was a significantly greater knowledge score in the decision aid group (66.2 ± 18.5 vs 57.2 ± 18.8, P = .005). Most clinicians and parents found the decision aid useful.

Conclusions: For parents facing extremely premature delivery, use of a decision aid did not impact maternal decisional conflict, but it significantly improved knowledge of complex information. A structured decision aid may improve comprehension of complex information.

Trial Registration: Clinicaltrials.gov: NCT01713894.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625526PMC
http://dx.doi.org/10.1016/j.jpeds.2019.02.023DOI Listing

Publication Analysis

Top Keywords

decision aid
28
premature delivery
16
decisional conflict
16
parents facing
8
facing extremely
8
extremely premature
8
randomized trial
8
knowledge prematurity
8
clinicians randomized
8
decision
8

Similar Publications

Artificial intelligence (AI) is a technique or tool to simulate or emulate human "intelligence." Precision medicine or precision histology refers to the subpopulation-tailored diagnosis, therapeutics, and management of diseases with its sociocultural, behavioral, genomic, transcriptomic, and pharmaco-omic implications. The modern decade experiences a quantum leap in AI-based models in various aspects of daily routines including practice of precision medicine and histology.

View Article and Find Full Text PDF

Motivation: Heavy usage of synthetic nitrogen fertilizers to satisfy the increasing demands for food has led to severe environmental impacts like decreasing crop yields and eutrophication. One promising alternative is using nitrogen-fixing microorganisms as biofertilizers, which use the nitrogenase enzyme. This could also be achieved by expressing a functional nitrogenase enzyme in the cells of the cereal crops.

View Article and Find Full Text PDF

A heat tolerance test (HTT) can aid in return-to-play decision making following exertional heat stroke (EHS). The HTT uses rectal temperature (T, >38.5°C) and heart rate thresholds (HR; >150 bpm) to identify "heat intolerance.

View Article and Find Full Text PDF

Confidence distributions are a frequentist alternative to the Bayesian posterior distribution. These confidence distributions have received more attention in the recent past because of their simplicity. In rare diseases, oncology, or in pediatric drug development, single-arm trials, or platform trials consisting of a series of single-arm trials are increasingly being used, both to establish proof-of-concept and to provide pivotal evidence for a marketing application.

View Article and Find Full Text PDF

Indications for haematopoietic cell transplantation and CAR-T for haematological diseases, solid tumours and immune disorders: 2025 EBMT practice recommendations.

Bone Marrow Transplant

September 2025

Clinical Hematology Department, Institut Català d'Oncologia-Hospitalet, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), University of Barcelona, Barcelona, Spain.

For over two decades, the EBMT has updated recommendations on indications for haematopoietic cell transplantation (HCT) practice based on clinical and scientific developments in the field. This is the ninth special EBMT report on indications for HCT for haematological diseases, solid tumours and immune disorders. Our aim is to provide guidance on HCT indications according to prevailing clinical practice in EBMT countries and centres.

View Article and Find Full Text PDF